The competition between energy-based devices (EBD) and dermal fillers is intensifying in the U.S. Aesthetics market. Recent data from Qsight Market View reveals that EBD procedures are closing in on the spending dominance traditionally held by dermal fillers.
One of the biggest challenges in the medical aesthetics industry is meeting aggressive sales quotas—a hurdle that can lead to burnout, high turnover, and diminishing motivation. Enter Qsight Prospector: the industry’s first data-powered tool designed to empower sales teams with precision-targeted insights.
With the end of year quickly approaching, the Aesthetics team at Guidepoint Qsight reviewed several years of trending data from Qsight Aesthetics Point-of-Sale and Qsight Aesthetics Tracker to unpack how behavior changes at MedSpas and Aesthetics practices in and around the holiday season.
The peripheral thrombectomy market in the United States has been witnessing significant growth and innovation in recent years. With new devices constantly entering the market, Qsight’s healthcare facilities purchasing data has been monitoring the impact of these new products.
Qsight has been monitoring the Axonics F15 SNM System since its launch in March 2022. Our healthcare facilities dataset shows that Axonics experienced a rapid increase in sales after the launch of this system, as this system offers a recharge-free option that now directly competes with Medtronic’s Interstim X.
As 2023 began with lingering economic concerns from 2022 (inflation, rising interest rates, risk of recession, etc.), the aesthetics industry’s hope for continued strong growth may be challenged.
With the leader of the TAVR market, Edwards Lifesciences, reporting a small miss in their third quarter earnings report, Guidepoint Qsight analyzed the short term and long-term effects of COVID-19 on the overall U.S. TAVR market.
Qsight’s HME/DME Purchasing Data provides clients with real-time intelligence into market share and purchasing insights in the non-acute medical device sector. We looked at our capture of insulin pumps from the top players to assess market share and market growth in the durable medical equipment channel.